PSC
WST icon

Portman Square Capital’s West Pharmaceutical WST Stock Holding History

Portman Square Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,500
Closed -$5.74M – 391
2024
Q1 		$5.74M Hold
14,500
– – 0.16% 144
2023
Q4 		$5.11M Sell
14,500
-600
-4% -$212K 0.12% 195
2023
Q3 		$5.67M Buy
+15,100
New +$5.84M 0.14% 170

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Portman Square Capital's WST Position: Q2 2024 in Review

Portman Square Capital sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 797 shares — an estimated $315K sold.

Portman Square Capital first reported a position in WST in Q3 2023 and held it in 3 quarters. The position peaked at $860K in Q4 2023. 776 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Portman Square Capital reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Portman Square Capital sold 797 West Pharmaceutical shares in Q2 2024, an estimated $315K.
  • Portman Square Capital first reported a position in West Pharmaceutical in Q3 2023 and held it in 3 quarters.
  • Portman Square Capital's West Pharmaceutical position peaked at $860K in Q4 2023.
  • 776 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Portman Square Capital's 13F filing for Q2 2024, filed 19 Jul 2024.